Se-Hoon Lee
Samsung Medical Center · Department of Hemato-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center · Seoul National University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Se-Hoon Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:56 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06383884 · Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 FusionSamsung Medical Center · recruiting · Solid Tumor, Adult · principal investigator
- Ph2NCT04939662 · Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer SubjectsSe-Hoon Lee · completed · Lung Cancer · study chair
- Ph2NCT04563871 · Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)Sehhoon Park · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- Ph2NCT04361825 · Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer SubjectsSe-Hoon Lee · completed · Small Cell Lung Cancer · principal investigator
- N/ANCT03578185 · Genomic Analysis to Identify a Predictive Biomarker for ImmunotherapySamsung Medical Center · recruiting · Lung Cancer · study chair
- N/ANCT02688894 · The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]Samsung Medical Center · recruiting · Small Cell Lung Cancers, Neuroendocrine Carcinoma · principal investigator
- N/ANCT02546895 · Prospective Registration of Head and Neck CancerSamsung Medical Center · completed · Head and Neck Cancer · principal investigator
- Ph2NCT01798446 · A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With TemsirolimusSeoul National University Hospital · completed · Renal Cell Carcinoma, Nonclear Cell, Temsirolimus Resistance · principal investigator
- Ph2NCT01689194 · Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck CancerSeoul National University Hospital · completed · Locally Advanced Head and Neck Squamous Cell Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:56 UTC. The ranking covers the 200 most relevant of 5455 PubMed records, and a shared surname and initials can bring in a namesake. All 5455 on PubMed
- 320 citationsRCR 34.5
- Colchicine in Acute Myocardial Infarction.N Engl J Med · 2025292 citationsRCR 76.5
- Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.N Engl J Med · 2025222 citationsRCR 85.6
- Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.N Engl J Med · 2025175 citationsRCR 63.3
- 169 citationsRCR 16.1
- 145 citationsRCR 14.7
- Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.N Engl J Med · 2024139 citationsRCR 18.4
- Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.N Engl J Med · 2025135 citationsRCR 26.4
- 125 citationsRCR 16.8
- 114 citationsRCR 23.0